Cantor Fitzgerald Reaffirms Hold Rating for Humana (HUM)
Cantor Fitzgerald reaffirmed their hold rating on shares of Humana (NYSE:HUM) in a research report report published on Tuesday morning. They currently have a $230.00 price target on the insurance provider’s stock. Cantor Fitzgerald also issued estimates for Humana’s FY2018 earnings at $12.03 EPS.
Several other brokerages have also issued reports on HUM. ValuEngine upgraded Humana from a hold rating to a buy rating in a research report on Friday, September 1st. Credit Suisse Group initiated coverage on Humana in a research report on Thursday, November 2nd. They issued a neutral rating and a $256.00 price objective for the company. BidaskClub upgraded Humana from a sell rating to a hold rating in a research report on Thursday, August 10th. UBS reiterated a neutral rating and issued a $250.00 price objective (up from $237.00) on shares of Humana in a research report on Wednesday, August 9th. Finally, Morgan Stanley boosted their price objective on Humana from $269.00 to $276.00 and gave the company an overweight rating in a research report on Thursday, August 17th. Twelve analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The stock currently has a consensus rating of Hold and an average target price of $255.80.
Humana (HUM) traded up $3.60 during trading on Tuesday, hitting $253.90. The stock had a trading volume of 1,031,700 shares, compared to its average volume of 1,382,630. The firm has a market cap of $35,757.88, a price-to-earnings ratio of 21.36, a P/E/G ratio of 1.72 and a beta of 0.88. Humana has a 52 week low of $186.25 and a 52 week high of $264.56. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.61 and a quick ratio of 1.61.
Humana (NYSE:HUM) last posted its earnings results on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.27 by $0.12. The company had revenue of $13.28 billion during the quarter, compared to analyst estimates of $13.41 billion. Humana had a return on equity of 15.99% and a net margin of 3.49%. The company’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period in the previous year, the company earned $3.18 EPS. equities research analysts expect that Humana will post 11.63 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.63%. The ex-dividend date is Thursday, December 28th. Humana’s dividend payout ratio is currently 12.59%.
Several institutional investors have recently made changes to their positions in the company. WFG Advisors LP raised its stake in shares of Humana by 4.5% during the 2nd quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock worth $113,000 after purchasing an additional 20 shares in the last quarter. Cadence Capital Management LLC raised its stake in shares of Humana by 0.4% during the 2nd quarter. Cadence Capital Management LLC now owns 5,682 shares of the insurance provider’s stock worth $1,367,000 after purchasing an additional 22 shares in the last quarter. Financial Advisors Network Inc. raised its stake in Humana by 3.4% in the 2nd quarter. Financial Advisors Network Inc. now owns 1,413 shares of the insurance provider’s stock valued at $340,000 after acquiring an additional 46 shares during the period. HL Financial Services LLC raised its stake in Humana by 0.9% in the 2nd quarter. HL Financial Services LLC now owns 7,963 shares of the insurance provider’s stock valued at $1,916,000 after acquiring an additional 68 shares during the period. Finally, Nordea Investment Management AB raised its stake in Humana by 1.0% in the 2nd quarter. Nordea Investment Management AB now owns 7,338 shares of the insurance provider’s stock valued at $1,766,000 after acquiring an additional 74 shares during the period. Institutional investors own 94.19% of the company’s stock.
WARNING: This piece was first reported by Watch List News and is owned by of Watch List News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.watchlistnews.com/cantor-fitzgerald-reaffirms-hold-rating-for-humana-hum/1752323.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.